4-year old Rebecca Riley,a Casualty of Psychiatric “Treatment”_BostonGlobe_NYT
“To me one of the miracle of children’s brains is that we don’t see more harm from these treatments.”
Evidence: Why you should never trust new wonder drugs
Pharmaceutical companies, much like the tobacco industry, have made fortunes by engaging in lies, deception, and illegal practices that are making people sick and causing premature deaths.
Bias/Fraud | Business of Medicine | Children Victimized | Corrupt Practices | Fraud | Psych Drugs | Research Integrity
Pharma Spin and Child Suicide Rates
Today's news reports about an increase suicide rate in 2004 offer an opportunity to witness how the media unwittingly disseminates pharmaceutical industry generated propaganda.
Pharma Spin Childhood Suicide Rates
Today’s news reports about an increase suicide rate in 2004 offer an opportunity to witness how the media unwittingly disseminates pharmaceutical industry generated propaganda.
Reputations for Sale ? BMJ-BBC-Panorama-Seroxat/ Paxil
BBC-Panorama–third in a series: The Secrets of Seroxat. "In the interests of patients and professional integrity" is to show those who have sold their reputations "intolerance and exposure."
Canadian Study: SSRI Increase Bone Fracture Risk
"Daily use of SSRIs was also associated with a four per cent reduction in bone mineral density of the hip and 2.4 per cent of the lower spine, the study found."
Role of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
YouTube Videos RE: Antidepressants
The video, "Zyprexa Drug Rep," was posted on YouTube on Dec. 18. When AHRP publicized its (Jan 4) there were something on the order of 38 hits. Since the Infomail was posted on the AHRP website and blog (http://ahrp.blogspot.com the number has reached: 1,429.
Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006
Only if one assumes that the FDA sees the drug industry as its client can some sense be made of December 13th meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee in Silver Springs, Maryland.
AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
"Most off-label use occurs without scientific support."
FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
MEDIA ALERT: Drug Victim advocates and Expert Scientists and Physicians
Expert Scientists, Psychiatrists, a Primary Care Physician, a Leading Attorney, will shed light on FDA’s Review of selected data Re: Antidepressants and Adult Suicidality One day prior to FDA’s Advisory Committee Hearing, December 13.